Gus Northrop

Gus Northrop has a diverse work experience in the biotechnology and pharmaceutical industry. Gus is currently serving as the Director of Corporate Strategy at Sparian Biosciences since January 2023. Prior to this role, Gus worked as a Program Director at Sparian Biosciences from October 2021 to January 2023.

Before joining Sparian Biosciences, Gus was a Senior Specialist at Merck, where they worked on the KEYTRUDA project from June 2020 to March 2021.

Gus also has educational experience from Columbia Business School, where they pursued an MBA from August 2017 to May 2020. During this time, they gained practical experience as an intern at BioMarin Pharmaceutical Inc. in June 2018, working on the ROCTAVIAN project.

Gus began their career at Globe Life Sciences Limited in 2012. Gus held various roles there, including Consultant, Senior Analyst, Business Analyst, and Research Analyst, from May 2017 to May 2017, November 2014 to May 2017, January 2013 to November 2014, and March 2012 to January 2013, respectively.

Gus started their professional journey as an Analyst Intern at IQVIA in November 2011 and served until February 2012.

Gus Northrop has an education history that consists of obtaining an MBA degree from Columbia Business School. Additionally, they earned a BA in Medical Science from the University of Oxford. The specific start and end years for each degree are not provided.